Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The pioneering work of members of the University has been recognised in The Queen's Birthday Honours List.

None © OUI/Greg Smolonski

Peter Donnelly, Professor of Statistical Science in the Wellcome Centre Trust for Human Genetics (WCTHG) at Oxford and Chief Executive Officer of Genomics plc, a University spin-out, is knighted for services to the understanding of human genetics in disease.

Professor Donnelly said: ‘I feel thrilled and tremendously honoured to have been awarded a knighthood by Her Majesty The Queen. This honour is a recognition not just of my work but also that of the outstanding researchers I have collaborated with over many years in pursuit of new insights into human genetics and its role in common diseases.’

Read more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.